ASCO 2026: Combining targeted immunotherapies with standard R-CHOP delays progression of aggressive B-cell lymphomas
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
ASCO 2026: Combining targeted immunotherapies with standard R-CHOP delays progression of aggressive B-cell lymphomas
ASCO 2026: Implanted tile-based radiation outperforms stereotactic radiotherapy for treatment of brain metastases
FDA approves durvalumab in combination with BCG for high-risk non-muscle invasive bladder cancer
Researchers develop a new sensor that could enable earlier detection of bladder cancer
Multidrug treatment using nanofibers shows promise for glioblastoma
Obesity may influence how breast cancer spreads
Naturally occurring molecule may help outsmart melanoma
Colorectal cancer risk linked to gut microbiome alterations
First comprehensive look at breast cancer in Native American women reveals key genetic differences
KRAS degradation induces rapid lung cancer regression in preclinical mouse models
Breast cancer: New approach to improve the effectiveness of immunotherapies
American Cancer Society updates colorectal cancer screening guideline: Major changes emphasize blood-based and at-home stool testing